Pharma Industry News

NICE recommends cenobamate for treatment of adult epilepsy patients in UK

Epilepsy affects over 600,000 people in the UK, which is approximately one in every 100 peopleOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]